PICTON MAHONEY ASSET MANAGEMENT
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1539041
Toronto, A6
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,904,837
-$123,985 QoQ
Shares Held
15,408
-1.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $70,922,376 across 23 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
165,000 | $21,900,450 | |
| 2 | QURE |
uniQure N.V.
|
181,215 | $8,346,762 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
65,880 | $7,314,656 | |
| 4 | ZYME |
Zymeworks Inc.
|
271,343 | $7,092,906 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
47,679 | $5,581,780 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
264,064 | $4,705,620 | |
| 7 | CGON |
CG Oncology, Inc.
|
63,867 | $4,537,750 | |
| 8 | ABVX |
Abivax S.A.
|
27,712 | $3,692,901 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,904,837 | 15,408 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $12,028,822 | 15,584 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $4,630,293 | 8,235 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1 | 1 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1 | 1 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1 | 1 | Shares | Sole | 2025-04-02 | |
| 2024-09-30 | $1 | 1 | Shares | Sole | 2024-11-04 | |
| 2020-06-30 | $4,047,488 | 6,490 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $4,455,646 | 9,125 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||